Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Survey that provided telling look into how Detroit blacks viewed 1967 riot largely ignored

Eisenberg says college athletes much less likely than other students to seek help with mental health conditions

Mitchell finds children who lose fathers suffer at cellular level

More News

Highlights

Neal Krause wins GSA's Robert Kleemeier Award

U-M awarded $58 million to develop ideas for preventing and treating health problems

Bailey, Eisenberg , and Fomby promoted at PSC

Former PSC trainee Eric Chyn wins PAA's Dorothy S. Thomas Award for best paper

More Highlights

Racial Treatment Trends in Localized/Regional Prostate Carcinoma: 1992-1999

Archived Abstract of Former PSC Researcher

Underwood, W., James S. Jackson, J.T. Wei, R. Dunn, E. Baker, S. Demonner, and D.P. Wood. 2005. "Racial Treatment Trends in Localized/Regional Prostate Carcinoma: 1992-1999." Cancer, 103:538-545.

BACKGROUND. African-American men have a greater incidence of and mortality from prostate carcinoma compared with white men, and they are less likely to receive definitive therapy (radical prostatectomy or external beam radiation therapy). During the 1990s, the use of brachytherapy increased; however, its influence on racial and ethnic prostate carcinoma treatment trends remains unclear. The objective of this study was to describe treatment trends over the period 1992-1999 for localized/ regional prostate carcinoma among white, Hispanic, and African-American men. METHODS. Using the Surveillance, Epidemiology, and End Results (SEER) registry data from 1992 through 1999, logistic regression models were used to determine whether the odds of receiving a specific treatment modality differed by racial and ethnic group and whether the differences changed over time when the models were adjusted for age, marital status, tumor grade, and SEER site (geography). RESULTS. The authors identified 142,340 men, including white men (81.670), Hispanic men (6.4%), and African-American men (12.0%). Racial and ethnic differences in the rates of use of androgen-deprivation therapy/expectant management were noted; however, these differences appeared to lessen over time (P < 0.001). The rate of utilization of radical prostatectomy increased for Hispanic men, remained flat for African-American men, and decreased for white men. The milization of brachytherapy and combination therapy increased for all three groups; however, the greatest increase in utilization was among white men. CONCLUSIONS. Further research will be required to determine the patient-level and provider-level variables that influence racial and ethnic treatment differences in localized/ regional prostate cancer. (C) 2004 American Cancer Society.

DOI:10.1002/cncr.20796 (Full Text)

Country of focus: United States of America.

Browse | Search : All Pubs | Next